The remaining studies were as follows: Li et al. [56] (Table 2) analysed 15 primary tumours and corresponding metastases of various origin obtained from Spanish patients (with multiple sites tested per patient), and found a KRAS mutation status concordance rate of 100 % (15/15). The gene discussed is KRAS; the disease is neoplasm.